On the spread and control of MDR-TB epidemics: An examination of trends in anti-tuberculosis drug resistance surveillance data

Drug Resistance Updates

Volumn 17, Issue 4-6, 2014, Pages 105-123

  Cohen, Ted ^a,b   Jenkins, Helen E ^a,c   Lu, Chunling ^a,c   McLaughlin, Megan ^c   Floyd, Katherine ^d   Zignol, Matteo ^d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Antibiotic resistance; MDR; Multidrug resistance; Surveillance; Trend; Tuberculosis

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; BOTSWANA; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; EPIDEMIC; ESTONIA; HEALTH SURVEY; HONG KONG; HUMAN; IMMIGRATION; LATVIA; MACAO; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANT TUBERCULOSIS; POPULATION RESEARCH; PORTUGAL; RUSSIAN FEDERATION; TREND STUDY; PROCEDURES; TUBERCULOSIS, MULTIDRUG-RESISTANT; WORLD HEALTH ORGANIZATION;

TUBERCULOSTATIC AGENT;

ANTITUBERCULAR AGENTS; HUMANS; POPULATION SURVEILLANCE; TUBERCULOSIS, MULTIDRUG-RESISTANT; WORLD HEALTH ORGANIZATION;

EID: 84914673924     PISSN: 13687646     EISSN: 15322084     Source Type: Journal    
DOI: 10.1016/j.drup.2014.10.001     Document Type: Article

References (46)

1. M.A. Aziz, and A. Wright The World Health Organization/International Union against tuberculosis and lung disease global project on surveillance for anti-tuberculosis drug resistance: a model for other infectious diseases Clin. Infect. Dis. 41 Suppl. 4 2005 S258 S262
2. G.H. Bai Trend of anti-tuberculosis drug resistance in Korea, 1994-2004 Int. J. Tuberc. Lung Dis. 11 5 2007 571 576
3. K. Blondal Countrywide management of pulmonary tuberculosis reverses increasing incidence Int. J. Tuberc. Lung Dis. 15 7 2011 892 898
4. S.M. Blower The intrinsic transmission dynamics of tuberculosis epidemics Nat. Med. 1 8 1995 815 821
5. C.C. Boeheme Rapid molecular detection of tuberculosis and rifampin resistance N. Engl. J. Med. 363 11 2010 1005 1015
6. T. Cohen Challenges in estimating the total burden of drug-resistant tuberculosis Am. J. Respir. Crit. Care Med. 177 12 2008 1302 1306
7. T. Cohen Mathematical models of the epidemiology and control of drug-resistant TB Expert Rev. Respir. Med. 3 1 2009 67 79
8. T. Cohen, B.L. Hedt, and M. Pagano Estimating the magnitude and direction of bias in tuberculosis drug resistance surveys conducted only in the public sector: a simulation study BMC Public Health 10 2010 355
9. D. Cox Some statistical methods connected with series events J. R. Stat. Soc. Ser. B - Methodol. 1955 129 164
10. I. Devaux Clusters of multidrug-resistant Mycobacterium tuberculosis cases Eur. Emerg. Infect. Dis. 15 7 2009 1052 1060
11. D.W. Dowdy Heterogeneity in tuberculosis transmission and the role of geographic hotspots in propagating epidemics Proc. Natl. Acad. Sci. U. S. A. 109 24 2012 9557 9562
12. C. Dye Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis Nat. Rev. Microbiol. 7 1 2009 81 87
13. C. Dye, and B.G. Williams Slow elimination of multidrug-resistant tuberculosis Sci. Transl. Med. 1 3 2009 3ra8
14. ECDC Tuberculosis in Latvia 2013 ECDC Stockholm
15. M.A. Espinal Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries JAMA 283 19 2000 2537 2545
16. D. Falzon, and F. Ait-Belghiti What is tuberculosis surveillance in the European Union telling us? Clin. Infect. Dis. 44 10 2007 1261 1267
17. D. Falzon Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data Lancet Infect. Dis. 13 8 2013 690 697
18. J. Furin Programmatic management of multidrug-resistant tuberculosis: models from three countries Int. J. Tuberc. Lung Dis. 15 10 2011 1294 1300
19. N.R. Gandhi Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa Lancet 368 9547 2006 1575 1580
20. L.L. Han Acquisition of drug resistance in multidrug-resistant Mycobacterium tuberculosis during directly observed empiric retreatment with standardized regimens Int. J. Tuberc. Lung Dis. 9 7 2005 818 821
21. B.L. Hedt Multidrug resistance among new tuberculosis cases: detecting local variation through lot quality-assurance sampling Epidemiology 23 2 2012 293 300
22. Y.P. Hong Treatment of bacillary pulmonary tuberculosis at the chest clinics in the private sector in Korea, 1993 Int. J. Tuberc. Lung Dis. 3 8 1999 695 702
23. H.E. Jenkins Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country Eur. Respir. J. 42 5 2013 1291 1301
24. V. Leimane Treatment outcome of multidrug/extensively drug-resistant tuberculosis in Latvia, 2000-2004 Eur. Respir. J. 36 3 2010 584 593
25. H.H. Lin Use of spatial information to predict multidrug resistance in tuberculosis patients Peru. Emerg. Infect. Dis. 18 5 2012 811 813
26. J. Manjourides Identifying multidrug resistant tuberculosis transmission hotspots using routinely collected data Tuberculosis (Edinb) 92 3 2012 273 279
27. Ministerio de Salud Norma tecnica de salud para el control de latuberculosis 2006 Ministerio de Salud Lima, Peru
28. Ministerio de Salud Norma tecnica de salud para el control de latuberculosis 2013 Ministerio de Salud Lima, Peru
29. D.M. Morens, and A.S. Fauci Emerging infectious diseases: threats to human health and global stability PLoS Pathog. 9 7 2013 pe1003467
30. E. Nathanson Multidrug-resistant tuberculosis management in resource-limited settings Emerg. Infect. Dis. 12 9 2006 1389 1397
31. M.C. Raviglione, and I.M. Smith XDR tuberculosis - implications for global public health N. Engl. J. Med. 356 7 2007 656 659
32. E. Sanchez-Padilla High prevalence of multidrug-resistant tuberculosis, Swaziland, 2009-2010 Emerg. Infect. Dis. 18 1 2012 29 37
33. H. Satti Extensively drug-resistant tuberculosis Lesotho. Emerg Infect Dis 14 6 2008 992 993
34. K.J. Seung The treatment of tuberculosis in South Korea Int. J. Tuberc. Lung Dis. 7 10 2003 912 919
35. UNAIDS, AIDSinfo Online Database (http://www.aidsinfoonline.org/devinfo/libraries/aspx/Home.aspx). Accessed Jan 4, 2014.
36. United Nations, 2012. Population, Department of Economic and Social Affairs, Population Division: New York.
37. A. van Deun Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories Int. J. Tuberc. Lung Dis. 15 1 2011 116 124
38. E. Vynnycky, and P.E. Fine The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection Epidemiol. Infect. 119 2 1997 183 201
39. WHO Guidelines for surveillance of drug resistance in tuberculosis 4th ed. 2009 World Health Organization Press Geneva
40. WHO Global Tuberculosis Report 2013 2013 World Health Organization Press Geneva
41. WHO, 2014a. WHO TB Burden Estimates. WHO's Global TB Database (http://www.who.int/tb/country/global-tb-database/en/index2.html). Accessed Jan 4, 2014.
42. WHO, 2014b. Data Provided by Countries and Territories: Case Notifications. (http://www.who.int/tb/country/data/download/en/). Accessed Jan 4, 2014.
43. WHO, 2014c. Data Explorer: National Health Accounts (NHA) Indicators. Global Health Expenditure Database (http://apps.who.int/nha/database/Select/Indicators/en). Accessed Jan 4, 2014.
44. World Bank, World Development Indicators (http://data.worldbank.org/data-catalog/world-development-indicators). Accessed Jan 4, 2014.
45. Y. Zhao National survey of drug-resistant tuberculosis in China N. Engl. J. Med. 366 23 2012 2161 2170
46. M. Zignol Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010 Bull. World Health Org. 90 2 2012 111 119D